Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

​​​​​​​​​​​​AUD/NZD likely to resume selloff as RBA slows tapering timeline​​​​​​​​​​​​

​AUD/NZD looking set for further downside, with RBA stretching out tapering timelines as vaccination rates lag behind New Zealand.

Source: Bloomberg

New Zealand to ramp up vaccination efforts

Australia and New Zealand have taken a somewhat questionable approach to this pandemic, with the positives of keeping cases down counteracted by the lack of any notable vaccination programme.

That decision to hold off on a widespread vaccination programme from the start raises the risk of continued lockdowns in response to relatively low numbers. The ability to raise protection is going to be crucial in a bid to stave off lockdowns and thus push onto a path of higher rates and strong economic growth.

With that in mind, the efforts in New Zealand are impressive, with daily vaccinations surging over the past month.

Source: Our World in Data

That recent vaccination drive has seen New Zealand overtake Australia in total vaccine protection, with the gap likely to grow given the daily rate of jabs seen above.

Source: Our World in Data

The Reserve Bank of Australia's (RBA) meeting overnight provided a somewhat mixed tone from the bank, with their plan to go ahead and taper from $5 billion to $4 billion also counteracted by a delay to any further steps. That shift sees the bank project that their next move could come in February rather than November as previously stated.

The AUD/NZD pair has understandably moved lower following that dovish shift, with the downtrend looking likely to kick back in. That plays into expectations that New Zealand will continue to vaccinate at a faster rate, which should also see a relatively more hawkish Reserve Bank of New Zealand (RBNZ).

The chart below highlights how AUD/NZD is coming off the back of a period of weakness that has seen four of five months post significant downside. Notably, we have also seen price drop below 1.0418, bringing a double top formation into play.

Source: ProRealTime

With the long-term downtrend in play here, there is a good chance we are set for further weakness. The intraday downtrend remains in play here, with the weakness seen today bringing a bearish continuation signal.

With that in mind, a bearish outlook holds for AUD/NZD, with a break up through 1.0541 bringing about a more positive outlook for the pair.

Source: ProRealTime

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.